In the News
SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential
ScienceDirect | September 22, 2020
How initial CHIRP participant samples are already being used to understand the immunology underlying the host response against SARS-CoV-2 virus. Here, samples from our first CHIRP participants showed that recovering COVID+ can mount robust immune cell responses (cells called “T” cells) against the virus. This suggests an important role for T cells in viral clearance and ways in which T cell function can be used to diagnose and potentially target SARS-CoV-2 virus.
Read Full Article
The Mystery of Why Some People Don’t Get Sick, Despite Coronavirus Infection
Mercury News | August 3, 2020
How CHIRP is enrolling patients with a range of COVID-19 disease severity in order to identify protective host genetic and immune responses that can be leveraged for future treatment strategies.
How Infection Sets In
UCSF Magazine | Summer 2020
How CHIRP plans to contribute to UCSF’s efforts to combat COVID-19.
Read Full Article
The Curious Case of the SF Doctor Who's Been Coronavirus-Positive Nearly 90 Days and Counting
SF Chronicle | May 30, 2020
How CHIRP plans to study unique individuals like Coleen to better understand how the host responds to SARS-CoV-2 virus.
Read Full Article